TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen

TORONTO, Canada & HAMBURG, Germany--(BUSINESS WIRE)-- #LifeSciences--Toronto Innovation Acceleration Partners (“TIAP”) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. The expansion goes along with a combined...

Click to view original post